This study identifies GSK3A as a key host kinase that promotes human adenovirus replication and phosphorylates viral protein L4-22K, revealing a potential therapeutic target for treating HAdV-related respiratory infections. This evidence concerns the gene GSK3A and respiratory tract infectious disorder.